Research Article
Serum Levels and Placental Expression of NGAL in Gestational Diabetes Mellitus
Table 2
Relationship of maternal NGAL levels with clinical and demographic characteristics in the gestational diabetes mellitus (GDM) and normal glucose tolerance (control) groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annotation: NGAL: neutrophil gelatinase-associated lipocalin; BMI: body mass index; FPG1: fasting plasma glucose in the second trimester; 1 hPG: 1 h plasma glucose after glucose loading; 2 hPG: 2 h plasma glucose after glucose loading; FPG2: fasting plasma glucose in the third trimester; FINS: fasting insulin level; HOMA-IR: HOMA-insulin resistance index; TC: total cholesterol; TG: triglycerol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; VLDL-C: very low-density lipoprotein cholesterol; r: Pearson’s correlation coefficient or Spearman’s correlation coefficient; values statistically evaluated as insignificant and significant. |